Trademarkia Logo

Canada

C$
Trademark Search in Canada
PSARLINK

View On IC.GC.CA

PSARLINK
APPROVED

on 19 Feb 2025

Last Applicant/ Owned by

MABLINK BIOSCIENCE

14 rue Waldeck-RousseauF-69006 LYON

FR

Serial Number

2069671 filed on 15th Jul 2020

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

PSARLINK

Trademark usage description

binding agents for bioconjugating cytotoxins, markers, highly active pharmaceutical ingredients, and monoclonal antibodies, for the treatment of cance Read More

Classification Information

Class [001]
Binding agents for bioconjugating cytotoxins, markers, highly active pharmaceutical ingredients, and monoclonal antibodies, for the treatment of cancer, lupus, Crohn's disease, sarcoidosis, gastritis, gout, viral infections, bacterial infections, and fungal infections; Cytotoxins, monoclonal antibodies, and highly active pharmaceutical ingredients for the treatment of cancer, lupus, Crohn's disease, sarcoidosis, gastritis, gout, viral infections, bacterial infections, and fungal infections; molecules and biomolecules, namely binding agents, markers, reagents, antibody fragments, antibodies, all intended for diagnostic use for medical purposes; Monoclonal antibodies for cancer treatment.

Classification kind code

11

Class [005]
Pharmaceutical preparations used in the treatment of cancer, lupus, Crohn's disease, sarcoidosis, gastritis, and gout, pharmaceutical preparations for the treatment of viral infections, namely, antiviral agents and pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, acquired immune deficiency syndrome, coronaviruses, Ebola and influenza, pharmaceutical preparations for the treatment of bacterial infections, namely, dermatological pharmaceutical preparations for the treatment of bacterial skin infections, and pulmonary infections such as pneumococcal, tuberculosis, and methicillin-resistant staphylococcus aureus, bacteremia and sepsis, and pharmaceutical preparations for the treatment of fungal infections.

Classification kind code

11

Mark Details

Serial Number

2069671

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 5th Apr 2022		Search Recorded
Submitted for opposition 20
on 5th Apr 2022		Examiner's First Report
Submitted for opposition 223
on 5th Apr 2022		Total Provisional Refusal
Submitted for opposition 256
on 11th Oct 2021		Notification of Possible Opposition Sent
Submitted for opposition 48
on 24th Feb 2021		Agent Changed
Submitted for opposition 257
on 10th Dec 2020		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 9th Dec 2020		Formalized
Submitted for opposition 1
on 9th Dec 2020		Created
Submitted for opposition 228
on 15th Jul 2020		International Registration
Submitted for opposition 30
on 15th Jul 2020		Filed